Contact
searchSearch
HMP Global
Login

Videos

Videos
Why Pathways Matter: Editorial Advisory Board Testimonials
03/24/2025
F. Randy Vogenberg, PhD, FASHP
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal...
03/24/2025
Journal of Clinical Pathways
Videos
Progress and Unmet Needs in Post-IO Treatment for Metastatic RCC
03/19/2025
Neil Shah, MD
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah...
03/19/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 2
03/17/2025
Gordon Kuntz; Carole Tremonti, RN, MBA
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology...
03/17/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 1
03/11/2025
Gordon Kuntz; Carole Tremonti, RN, MBA
In this interview, experts Gordon Kuntz and Carole Tremonti, RN, MBA, discuss the goals, challenges, and collaborative efforts of the Predictable Cost of Care Working Group, highlighting its role in developing a standardized model for...
In this interview, experts Gordon Kuntz and Carole Tremonti, RN, MBA, discuss the goals, challenges, and collaborative efforts of the Predictable Cost of Care Working Group, highlighting its role in developing a standardized model for...
In this interview, experts...
03/11/2025
Journal of Clinical Pathways
Zibelman Headshot
Videos
Exploring the Potential of Nivolumab and Axitinib in Renal Cell Carcinoma
03/11/2025
Matthew Zibelman, MD
Matthew Zibelman, MD, shares results from his study on combination systemic therapy with tyrosine kinase inhibitor nivolumab and immune checkpoint inhibitor axitinib for patients with metastatic renal cell carcinoma.
Matthew Zibelman, MD, shares results from his study on combination systemic therapy with tyrosine kinase inhibitor nivolumab and immune checkpoint inhibitor axitinib for patients with metastatic renal cell carcinoma.
Matthew Zibelman, MD, shares...
03/11/2025
Journal of Clinical Pathways
BDHC Thumbnail
Videos
Expanding Access to Clinical Trials: What Oncologists and Payers Need to Know
02/28/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down...
02/28/2025
Cancer Care Business Exchange
Videos
Why Pathways Matter: Editorial Advisory Board Testimonials
02/28/2025
Alan J. Balch, PhD, MSc
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal...
02/28/2025
Journal of Clinical Pathways
Doshi Headshot
Videos
Assessing Real-World Outcomes of First-Line Ipilimumab and Nivolumab for Advanced Renal Cell Carcinoma
02/18/2025
Sahil Doshi, MD
In this interview, Sahil Doshi, MD, discusses the outcomes of a recent trial he authored on first-line ipilimumab and nivolumab for metastatic renal cell carcinoma, highlighting its implications for clinical practice and payer considerations.
In this interview, Sahil Doshi, MD, discusses the outcomes of a recent trial he authored on first-line ipilimumab and nivolumab for metastatic renal cell carcinoma, highlighting its implications for clinical practice and payer considerations.
In this interview, Sahil Doshi,...
02/18/2025
Journal of Clinical Pathways
Headshot
Videos
The Role of ctDNA Clearance in RCC: Retrospective Analysis and Clinical Implications
02/13/2025
Adanma Ayanambakkam, MD
In this interview, Adanma Ayanambakkam, MD, discusses his study on the use of circulating tumor DNA (ctDNA) clearance as a biomarker in renal cell carcinoma (RCC), highlighting findings from a single-institution retrospective study and its...
In this interview, Adanma Ayanambakkam, MD, discusses his study on the use of circulating tumor DNA (ctDNA) clearance as a biomarker in renal cell carcinoma (RCC), highlighting findings from a single-institution retrospective study and its...
In this interview, Adanma...
02/13/2025
Journal of Clinical Pathways
Houda Hachad, PharmD
Videos
Implementing PGx Testing in Oncology: Best Practices, Barriers, and Benefits
02/12/2025
Houda Hachad, PharmD
Houda Hachad, PharmD, highlights best practices for implementing PGx testing in oncology and the barriers to its more widespread adoption.
Houda Hachad, PharmD, highlights best practices for implementing PGx testing in oncology and the barriers to its more widespread adoption.
Houda Hachad, PharmD, highlights...
02/12/2025
Journal of Clinical Pathways
JCP January/February 2025

Current Issue

February 2025
Volume 11
Issue 1
Current Issue
Issue Archive

Popular Articles

Conference Coverage
Case Studies of New Patient Access Programs at Two Cancer Centers
04/27/2023
Grace Taylor, MS, MA
Kimberly Bell, RN, MBA, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic, and Danielle McLaughlin, MPH, University of California San Diego, Moores Cancer Center, highlight different strategies...
Kimberly Bell, RN, MBA, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic, and Danielle McLaughlin, MPH, University of California San Diego, Moores Cancer Center, highlight different strategies...
Kimberly Bell, RN, MBA, Case...
04/27/2023
Journal of Clinical Pathways
Adam Kittai, MD
Videos
A Real-World Analysis of Factors Leading to Racial Disparities in the Overall Survival of Patients with CLL
06/22/2023
Adam Kittai, MD
Adam Kittai, MD, The Ohio State University Comprehensive Cancer Center, discusses his study on the causes of racial disparities in the overall survival of patients with chronic lymphocytic leukemia.
Adam Kittai, MD, The Ohio State University Comprehensive Cancer Center, discusses his study on the causes of racial disparities in the overall survival of patients with chronic lymphocytic leukemia.
Adam Kittai, MD, The Ohio State...
06/22/2023
Journal of Clinical Pathways
Christopher D'Avella, MD.
Videos
Using Provider Feedback to Improve Efficiency and Utilization of the Flatiron Assist EMR-Based Pathways Tool
08/14/2023
Christopher D'Avella, MD
Christopher D’Avella, MD, talks about his institution’s use of the Flatiron Assist pathways program, and how the improvements made to the tool as a result of provider feedback increased the efficiency and utilization of the program.
Christopher D’Avella, MD, talks about his institution’s use of the Flatiron Assist pathways program, and how the improvements made to the tool as a result of provider feedback increased the efficiency and utilization of the program.
Christopher D’Avella, MD, talks...
08/14/2023
Journal of Clinical Pathways
News
CPC & CBEx 2023: Critical Trends in the Oncology Landscape
10/06/2023
Brandon Twyford
To open Friday’s schedule of sessions at the Clinical Pathways Congress & Cancer Care Business Exchange, Lee Blansett, MBA, Executive Vice President for HMP Market Access Insights, discussed critical trends in today’s oncology...
To open Friday’s schedule of sessions at the Clinical Pathways Congress & Cancer Care Business Exchange, Lee Blansett, MBA, Executive Vice President for HMP Market Access Insights, discussed critical trends in today’s oncology...
To open Friday’s schedule of...
10/06/2023
Cancer Care Business Exchange
News
The Impact of Lower Cost Alternatives or Biosimilars on The Cost of Key Cancer Drugs
10/28/2023
Grace Taylor, MS, MA
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and...
10/28/2023
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use